34 (5), e3004
Acute intermittent porphyria
Mowaad NA, Baraka SM, Ibrahim S, Mansour DA, Korany RMS, El-Sayed AF, et al
Nareg Varjabedian , Regulatory Affairs Team Lead at ClinChoice, shared a post on LinkedIn: Emerging Clinical Insight: GLP-1 Agonists May Interfere with FDG PET-CT Imaging In recent years, GLP-1 receptor agonistsincluding semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro)have revolutionized the management of type 2 diabetes and obesity
HA Rejuve is a unique technology that uses precision micro-injections to both smooth the skin with Hyaluronic Acid (HA) and resurface the skin from the inside-out using a powerful antioxidant, glutathione
Effectiveness of beinaglutide in a patient with late dumping syndrome after gastrectomy